Skip to content

A study protocol for analyzing the benefit and prognosis of combined Chinese and Western medicine treatments for patients with limited-stage small cell lung cancer based on real-world clinical information and microenvironmental markers

A study protocol for analyzing the benefit and prognosis of combined Chinese and Western medicine treatments for patients with limited-stage small cell lung cancer based on real-world clinical information and microenvironmental markers

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025001919
Enrollment
Unknown
Registered
2025-10-15
Start date
2025-02-01
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

limited stage small cell lung cancer

Interventions

Western Medicine Treatment Cohort:not applicable
Integrated Chinese and Western Medicine Treatment Cohort:not applicable

Sponsors

Beijing Hospital of Traditional Chinese Medicine Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) patients with histologically or cytologically confirmed small-cell lung cancer with confirmed staging of limited stage; 2) age =18 years; 3) had been or were undergoing standardized treatment with Western medicine; 4) agreed to sign an informed consent; 5) patients with good adherence to long-term follow-up.

Exclusion criteria

Exclusion criteria: 1) those whose pathologic type was mixed small cell lung cancer or combined with other primary tumors at the time of diagnosis; 2) patients who were pregnant or breastfeeding; 3) patients with psychiatric disorders;4) those with incomplete critical diagnostic information such as pathology reports.

Design outcomes

Primary

MeasureTime frame
Disease-free survival;Progression-Free-Survival;

Secondary

MeasureTime frame
Chinese Medicine Clinical Symptom Score;Evaluation of the efficacy of tumor treatment;

Countries

China

Contacts

Public ContactYu Mingwei

Beijing Hospital of Traditional Chinese Medicine Capital Medical University

yumingwei1120@163.com13810081763

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026